Viking Therapeutics (VKTX) Barely Up Since Jim Cramer Advised Selling The Stock

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the 20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of. Viking Therapeutics Inc. (NASDAQ:VKTX) is a biotechnology company developing drugs for ailments such as anemia and non-alcoholic steatohepatitis. Its shares are up by 49% over the past year and are down by 2.4% year-to-date. Several catalysts appear to have affected Viking Therapeutics Inc. (NASDAQ:VKTX)’s shares since Cramer discussed them in January 2025. One major event occurred on August 19th when the stock dipped by an unbelievable 42%. On that day, the firm reported the latest results for its VK-2735 drug that aims to work with the weight loss GIP and GLP-1 receptors. The drug’s mid-stage trial saw participants lose 12% of their body weight, while, according to media reports, investors were aiming for higher results. Since the dip in August, Viking Therapeutics Inc. (NASDAQ:VKTX)’s shares are up by 41%. Here is what Cramer said about the firm on Mad Money:

“I want you to sell Viking Therapeutics and roll it into Viking Holdings, which is a fantastic cruise line, does not save lives, does not lower your blood pressure… but darn, you’ll have a good time.”

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.